Phosphate Binders

Phosphate-Binder Swap Has Benefits

ORLANDO—Switching end-stage renal disease patients to lanthanum carbonate monotherapy from a phosphate binder therapy maintains their previous serum phosphorus control, and aids patient and physician satisfaction.

Next post in News